Cargando…

The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy

Adeno-associated virus (AAV)-based vectors are widely used for gene therapy, but the effect of pre-existing antibodies resulting from exposure to wild-type AAV is unclear. In addition, other poorly defined plasma factors could inhibit AAV vector transduction where antibodies are not detected. To bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, Brian R., Sandza, Krystal, Holcomb, Jennifer, Crockett, Lucy, Hayes, Gregory M., Arens, Jeremy, Fonck, Carlos, Tsuruda, Laurie S., Schweighardt, Becky, O’Neill, Charles A., Zoog, Stephen, Vettermann, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513774/ https://www.ncbi.nlm.nih.gov/pubmed/31193016 http://dx.doi.org/10.1016/j.omtm.2019.03.006

Ejemplares similares

Strategy to detect pre-existing immunity to AAV gene therapy
por: Falese, L, et al.
Publicado: (2017)

Ultra-sensitive AAV capsid detection by immunocapture-based qPCR following factor VIII gene transfer
por: Sandza, Krystal, et al.
Publicado: (2021)

Lack of germline transmission in male mice following a single intravenous administration of AAV5-hFVIII-SQ gene therapy
por: Fonck, Carlos, et al.
Publicado: (2022)

Early Phase Clinical Immunogenicity of Valoctocogene Roxaparvovec, an AAV5-Mediated Gene Therapy for Hemophilia A
por: Long, Brian R., et al.
Publicado: (2021)

Confirmatory detection of neutralizing antibodies to AAV gene therapy using a cell-based transduction inhibition assay
por: Kasprzyk, Theresa, et al.
Publicado: (2022)

Monitoring cell-mediated immune responses in AAV gene therapy clinical trials using a validated IFN-γ ELISpot method
por: Patton, Kathryn S., et al.
Publicado: (2021)

Young mice administered adult doses of AAV5-hFVIII-SQ achieve therapeutic factor VIII expression into adulthood
por: Zhang, Lening, et al.
Publicado: (2022)

Pharmacokinetic and Pharmacodynamic Evaluation of Elosulfase Alfa, an Enzyme Replacement Therapy in Patients with Morquio A Syndrome
por: Qi, Yulan, et al.
Publicado: (2014)

Pharmacokinetic, pharmacodynamic, and immunogenic rationale for optimal dosing of pegvaliase, a PEGylated bacterial enzyme, in adult patients with phenylketonuria
por: Qi, Yulan, et al.
Publicado: (2021)

Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A
por: Klamroth, Robert, et al.
Publicado: (2022)

AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9
por: Li, Ang, et al.
Publicado: (2020)

Threshold for Pre-existing Antibody Levels Limiting Transduction Efficiency of Systemic rAAV9 Gene Delivery: Relevance for Translation
por: Meadows, Aaron S., et al.
Publicado: (2019)

Enhancing the Clinical Potential of AAV Vectors by Capsid Engineering to Evade Pre-Existing Immunity
por: Bartel, Melissa, et al.
Publicado: (2011)

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction
por: Fitzpatrick, Zachary, et al.
Publicado: (2018)

Effective Depletion of Pre-existing Anti-AAV Antibodies Requires Broad Immune Targeting
por: Velazquez, Victoria M., et al.
Publicado: (2017)

Gene Therapy with BMN 270 Results in Therapeutic Levels of FVIII in Mice and Primates and Normalization of Bleeding in Hemophilic Mice
por: Bunting, Stuart, et al.
Publicado: (2018)

AAV9-NGLY1 gene replacement therapy improves phenotypic and biomarker endpoints in a rat model of NGLY1 Deficiency
por: Zhu, Lei, et al.
Publicado: (2022)

Survival of cancer patients with pre-existing heart disease
por: O’Neill, Ciaran, et al.
Publicado: (2022)

Validation of an IFN-gamma ELISpot assay to measure cellular immune responses against viral antigens in non-human primates
por: Yang, Fan, et al.
Publicado: (2021)

Therapeutic hFIX Activity Achieved after Single AAV5-hFIX Treatment in Hemophilia B Patients and NHPs with Pre-existing Anti-AAV5 NABs
por: Majowicz, Anna, et al.
Publicado: (2019)

Pre-existing humoral immunity and complement pathway contribute to immunogenicity of adeno-associated virus (AAV) vector in human blood
por: Smith, Corinne J., et al.
Publicado: (2022)

A sensitive AAV transduction inhibition assay assists evaluation of critical factors for detection and concordance of pre-existing antibodies
por: Pan, Yonghua, et al.
Publicado: (2023)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Association of immune response with efficacy and safety outcomes in adults with phenylketonuria administered pegvaliase in phase 3 clinical trials
por: Gupta, Soumi, et al.
Publicado: (2018)

Predicting HIV Pre-exposure Prophylaxis Efficacy for Women using a Preclinical Pharmacokinetic-Pharmacodynamic In Vivo Model
por: Wahl, Angela, et al.
Publicado: (2017)

Genetic variation in aryl N-acetyltransferase results in significant differences in the pharmacokinetic and safety profiles of amifampridine (3,4-diaminopyridine) phosphate
por: Haroldsen, Peter E, et al.
Publicado: (2015)

Coronavirus Disease 2019 Infection in Children with Pre-Existing Heart Disease
por: Simpson, Megan, et al.
Publicado: (2020)

Targeting the somatosensory system with AAV9 and AAV2retro viral vectors
por: Skorput, Alexander G. J., et al.
Publicado: (2022)

Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study
por: Acosta, Andres, et al.
Publicado: (2015)

Pre-Existing Comorbidities Diminish the Likelihood of Seropositivity after SARS-CoV-2 Vaccination
por: Amraotkar, Alok R., et al.
Publicado: (2022)

Editorial: Pharmacokinetics and Pharmacodynamics of Pre-Exposure Prophylaxis Against HIV
por: von Kleist, Max, et al.
Publicado: (2020)

Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Basner-Tschakarjan, Etiena, et al.
Publicado: (2014)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

Effect of marriage on pre-existing psychoses
por: Behere, Prakash B., et al.
Publicado: (2011)

Trauma in the Aggravation of Pre-Existing Disease
por: M'Bride, J. Graham
Publicado: (1913)

Reduction in Noise-Induced Functional Loss of the Cochleae in Mice with Pre-Existing Cochlear Dysfunction Due to Genetic Interference of Prestin
por: Cai, Qunfeng, et al.
Publicado: (2014)

Heat-Related Illness Is Associated with Lack of Air Conditioning and Pre-Existing Health Problems in Detroit, Michigan, USA: A Community-Based Participatory Co-Analysis of Survey Data
por: Cardoza, Jacqueline E., et al.
Publicado: (2020)

Animal models in compartment syndrome: a review of existing literature
por: O’Neill, Dillon C., et al.
Publicado: (2022)

Rational Design of AAV-rh74, AAV3B, and AAV8 with Limited Liver Targeting
por: Chan, Christopher, et al.
Publicado: (2023)

AMG 900, a potent inhibitor of aurora kinases causes pharmacodynamic changes in p-Histone H3 immunoreactivity in human tumor xenografts and proliferating mouse tissues
por: Juan, Gloria, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k9ihs9fpg8un5in0s4ojlst57t